Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-Year Analysis of Susceptibilities of Candida Species to Fluconazole and Voriconazole as Determined by CLSI…

By M. Pfaller, D. Diekema, D. Gibbs, V. Newell, D. Ellis, V. Tullio, A. Rodloff, W. Fu, T. A. Ling. Journal of Clinical Microbiology, 2010

759 citations recorded by the source corpus.

Subfields: Epidemiology, Infectious Diseases, Small Animals

View Paper: https://www.semanticscholar.org/paper/d1a9e7e379bb40bc1c6b52b2ed0450eb0d48406e

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. J. Guinea
2. M. Pfaller
3. D. Diekema
4. Mariana Castanheira
5. Ronald N. Jones
6. J. Turnidge

In Infectious Diseases

1. J. Guinea
2. M. Pfaller
3. D. Diekema
4. Mariana Castanheira
5. J. Turnidge
6. Ronald N. Jones

In Small Animals

1. J. Guinea
2. M. Pfaller
3. D. Diekema

Citations in the corpus

• Azole Antifungal Resistance in Candida albicans and Emerging Non-albicans Candida Species (2017, background): “In particular, patients with hematologic malignancies and bone marrow transplants have been shown to be at increased risk of C. krusei infection (Merz et al., 1986; Wingard et al., 1991; Pfaller et al., 2008).”
• Twenty Years of the SENTRY Antifungal Surveillance Program: Results for Candida Species From 1997–2016 (2019, methodology): “We have shown variable cross-resistance between fluconazole and voriconazole when tested against the common species of Candida causing IC [53, 63, 64].”
• Global trends in the distribution of Candida species causing candidemia. (2014, methodology): “Compiled data from the ARTEMIS DISK registry are useful when studying temporal changes in the frequency of invasive Candida spp isolates in large geographic areas from 1997 to 2007 [16,27,28] (Fig.”